Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral nicorandil in primary percutaneous coronary intervention (PPCI)
IRCT20140512017666N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nicorandil in myocardial infarction (MI), sponsored by Tabriz University of Medical Sciences. Started Mar 2018; status: completed.
02
Drugs
nicorandil
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20140512017666N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140512017666N1.